Company Chordate Medical Holding AB
Equities
CMH
SE0009495559
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0548 SEK | +0.74% | -14.38% | -65.84% |
05-07 | Chordate Medical Receives Patent Approval in the US | CI |
03-22 | Chordate Medical Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 3
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Neuromodulation Treatment Technology
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +799.66% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
International
50.6
%
| 0 | 44.9 % | 0 | 50.6 % | +913.93% |
European Union
49.4
%
| 0 | 55.1 % | 0 | 49.4 % | +706.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 31/10/14 | |
Director of Finance/CFO | 56 | 01/10/17 | |
Jan Hermansson
CTO | Chief Tech/Sci/R&D Officer | 68 | 31/12/11 |
Jan Lindberg
CTO | Chief Tech/Sci/R&D Officer | 68 | 31/12/11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 31/05/14 | |
Gunilla Lundmark
BRD | Director/Board Member | 61 | 31/03/17 |
Chief Executive Officer | 63 | 31/10/14 | |
Director/Board Member | 62 | 30/04/23 | |
Chairman | 50 | 31/10/14 | |
Director/Board Member | 45 | 30/09/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 306,024,605 | 113,096,842 ( 36.96 %) | 0 | 36.96 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-65.84% | 2.5M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- CMH Stock
- Company Chordate Medical Holding AB